Eli Lilly Corp. buy Morgan Stanley
Start price
16.02.24
/
50%
€714.50
Target price
16.02.25
€883.50
Performance (%)
14.62%
Price
08:11
€816.60
Summary
This prediction is currently active. The prediction currently has a performance of 14.62%. Dividends of €2.38 are taken into consideration when calculating the performance. This prediction currently runs until 16.02.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eli Lilly Corp. | -6.084% | -6.084% |
iShares Core DAX® | -3.429% | 3.133% |
iShares Nasdaq 100 | -6.121% | -1.433% |
iShares Nikkei 225® | -7.364% | 1.018% |
iShares S&P 500 | -4.366% | 0.247% |
Comments by Morgan_Stanley for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Morgan Stanley from $805.00 to $950.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€524.50
05.09.23
05.09.23
€597.50
05.09.24
05.09.24
56.13%
06.09.24
06.09.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€476.00
10.08.23
10.08.23
€558.63
10.08.24
10.08.24
72.69%
11.08.24
11.08.24